Enterprise Evidence Report · NR-REPORT-V2.0

Canada
Neuroscience Intelligence

Canada neuroscience evidence report: current clinical, research, institution and source-linked intelligence.

Evidence rank #5 of 50 · Data maturity A · Research score 50.8 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.

⚗
431Curated trials
↗
109Recruiting trials
▦
707Publications
⌂
289Institutions

Executive interpretation

Canada ranks #5 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.

Methodology status

Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.

Methodology →

Leading sponsors

Merck Sharp & Dohme LLC198 recruiting
University of Calgary181 recruiting
Pfizer132 recruiting
Hoffmann-La Roche135 recruiting
Centre for Addiction and Mental Health102 recruiting
Eli Lilly and Company100 recruiting
University of Toronto92 recruiting
McGill University81 recruiting
McMaster University83 recruiting
University Health Network, Toronto82 recruiting

Disease activity

Alzheimers71trials
Parkinsons63trials
Depression35trials
Epilepsy25trials
Autism23trials
Stroke22trials
Other Neurology20trials
Pain Neuropathy15trials
Adhd15trials
Multiple Sclerosis13trials

Research institutions

Hôpital Charles-Le MoyneOpenAlexlinked institution
Providence Health CareOpenAlexlinked institution
Unity Health TorontoOpenAlexlinked institution
BruyèreOpenAlexlinked institution
Population Health Research InstituteOpenAlexlinked institution
Canadian Heart Research CentreOpenAlexlinked institution
Alberta Children's HospitalOpenAlexlinked institution

Clinical evidence trail

NCT07804615A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic TherapyRECRUITING
NCT07675551Peel Family Diabetes Prevention ProgramRECRUITING
NCT07671248Tirzepatide in the Treatment of Cannabis Use DisorderNOT_YET_RECRUITING
NCT07609082Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Ovarian Cancer SurgeryNOT_YET_RECRUITING
NCT07575932A Study of PF-08653945 and PF-08653944 in Adults With Overweight or ObesityACTIVE_NOT_RECRUITING
NCT07567482Exoskeleton-Assisted Mobility in Aging and in Parkinson's DiseaseRECRUITING
NCT07531745ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet SyndromeRECRUITING
NCT07493265A Study to Evaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyRECRUITING
NCT07477431Levetiracetam for Persons at Risk for Alzheimer's DiseaseRECRUITING
NCT07434973Stratification and Treatment in Early Psychosis Study - PROMOTENOT_YET_RECRUITING
NCT07367022Portable Sleep Monitors in Children With Autism Spectrum DisorderRECRUITING
NCT07366515Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery PatientsRECRUITING

Research evidence trail

PUBMEDThe putative role of the microbiota in the development of neuropsychiatric disorders following early childhood malnutrition.2026-12-31
PUBMEDEpisode-state-associated and shared intrinsic functional network patterns in bipolar disorder.2026-12-15
PUBMEDProtective effects of central leptin on whole-body energy homeostasis following acute olanzapine exposure.2026-12-15
PUBMEDSuicidal ideation at psychiatric emergency presentation predicts trajectories of functional disability and symptom burden in mood and anxiety disorders: A prospective cohort study.2026-12-15
PUBMEDThe effect of vortioxetine on cognitive function in older adults with major depressive disorder: A systematic review.2026-12-15
PUBMEDOnabotulinumtoxinA for Painful Foot Dystonia in Parkinson Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.2026-12-01
PUBMEDFDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook.2026-12-01
PUBMEDEmergency department use trajectories over a 10-year period among patients with substance-related disorders.2026-12-01
PUBMEDWhen trauma triggers craving: meta-analytic evidence for the mediating role of negative affect among trauma-exposed individuals who use substances.2026-12-01
PUBMEDElectrophysiological signatures of posttraumatic stress disorder (PTSD) reflect frequency-specific alterations in large scale cortical coordination during resting state magnetoencephalography (MEG).2026-12-01
PUBMEDRelations between pregnancy insomnia, relationship conflict, and stress during the COVID-19 pandemic: From pregnancy through early parenthood.2026-12-01
PUBMEDEffects of probiotic supplementation on sleep and psychological outcomes in adults with mild-to-moderate insomnia symptoms and work-related stress: A randomized, placebo-controlled, double-blind trial.2026-12-01

World Bank context

IT.NET.USER.ZSinternet_users_pct94.4% · 2024
NY.GDP.MKTP.CDgdp_current_usd$2,243.6B · 2024
NY.GDP.PCAP.CDgdp_per_capita_usd$54,340 · 2024
SE.PRM.ENRRschool_enrollment_primary_pct95.01 · 2023
SE.SEC.ENRRschool_enrollment_secondary_pct104.32 · 2023
SH.XPD.CHEX.GD.ZScurrent_health_expenditure_pct_gdp11.3% · 2024
SH.XPD.CHEX.PC.CDcurrent_health_expenditure_per_capita_usd$6,378 · 2024
SH.XPD.GHED.GD.ZSgovernment_health_expenditure_pct_gdp7.9% · 2024
SP.DYN.CBRT.INbirth_rate_crude8.90 · 2024
SP.POP.TOTLpopulation_total41,288,599 · 2024
SP.URB.TOTL.IN.ZSurban_population_pct82.7% · 2024

Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.

Sources and provenance

ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.

Limitations

Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.